Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr

Glenmark Pharmaceuticals has received board approval to sell 75% stake in subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,652 crore.
Share this Video

READ MORE:

Glenmark Pharmaceuticals |Glenmark Pharma |Glenmark Life Sciences |Glenmark Life Sciences to Nirma Ltd |Nirma Ltd |Rs 5652 crore.
Business News › Markets › Stocks › News › Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr

Browse Companies

ABCDEFGHIJKLMNOPQRSTUVWXYZ
123456789

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Download ET APP


Follow us on


Powered by

become a member

Terms of Use & Grievance Redressal Policy
DNPA Code of Ethics|Privacy Policy|Archive|Delete Data|Feedback|

Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service

Do Not Sell My Personal Information
Success
This article has been saved